+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ornithine"

Cirrhosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cirrhosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Urea Cycle Disorders - Pipeline Insight, 2024 - Product Thumbnail Image

Urea Cycle Disorders - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2020 - Product Thumbnail Image

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 53 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Ornithine is a drug used to treat liver and kidney disorders. It is a derivative of the amino acid arginine and is used to reduce ammonia levels in the body. It is also used to treat urea cycle disorders, a group of genetic disorders that affect the body's ability to break down proteins. Ornithine is available in both oral and injectable forms. It is often used in combination with other drugs to treat liver and kidney disorders. Ornithine is a popular drug in the market for liver and kidney disorders. It is used to reduce ammonia levels in the body and to treat urea cycle disorders. It is available in both oral and injectable forms and is often used in combination with other drugs. Some companies in the Ornithine market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more